Literature DB >> 3491409

Establishment of monoclonal antibodies which possess the same characteristics as the naturally occurring thymocytotoxic autoantibodies (NTA).

K Tani, H Sakamoto, K Katoh, K Matsunagai, S Yamada, K Okuda, B S Handwerger.   

Abstract

Autoantibody-secreting hybrid cell lines were obtained by fusion of spleen cells from unimmunized (NZB X NZW) F1 mice with the HAT-sensitive mouse myeloma cell line SP2/0-Ag14. Eight hybridoma cell lines producing autoantibodies to mouse thymocytes were cloned and the resultant antibodies were partially characterized. All eight monoclonal antibodies lysed mouse thymocytes in the presence of rabbit complement. The anti-thymocyte cytotoxic antibody activities were absorbed with thymocytes, lymph node cells, unfractionated spleen cells, and splenic T cells; but not with bone marrow cells, splenic B cells, or homogenates of mouse kidney, liver, or striated muscle cells. In addition, the cytotoxic activities of culture supernatants from seven of the eight hybrid clones were absorbed with mouse brain tissue homogenates. Isotyping of the monoclonal antibodies revealed that five were IgM and three were IgG2a. Mouse thymocytes sensitized with each of the eight monoclonal antibodies in vitro became highly susceptible to phagocytosis by syngeneic macrophages. The monoclonal antithymocyte antibodies, thus, appear to be similar to the naturally occurring, (NZB X NZW) F1 thymocytotoxic autoantibodies (NTA) described by Shirai et al.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491409     DOI: 10.1007/BF00270660

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  35 in total

1.  Immunoregulation in New Zealand mice. I. Failure of the transfer of syngeneic spleen or thymus cells to influence the natural disease in New Zealand mice.

Authors:  A A Hoffman; R J Harbeck
Journal:  Arthritis Rheum       Date:  1979-04

2.  Induction of thymocytotoxic autoantibodies after injection of bacterial lipopolysaccharides in mice.

Authors:  S Izui; T Kobayakawa; J Louis; P H Lambert
Journal:  Eur J Immunol       Date:  1979-04       Impact factor: 5.532

3.  Effects of natural thymocytotoxic autoantibody of NZB mice and of specifically prepared antilymphocyte serum on the tissue distribution of 51 Cr-labeled lymphocytes.

Authors:  T Shirai; T Yoshiki; R C Mellors
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

4.  Age-decrease of cells sensitive to an autoantibody-specific for thymocytes and thymus-dependent lymphocytes in NZB mice.

Authors:  T Shirai; T Yoshiki; R C Mellors
Journal:  Clin Exp Immunol       Date:  1972-12       Impact factor: 4.330

5.  Surface alloantigens of plasma cells.

Authors:  T Takahashi; L J Old; E A Boyse
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

Review 6.  The cellular and genetic basis of murine lupus.

Authors:  A D Steinberg; D P Huston; J D Taurog; J S Cowdery; E S Ravecheé
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

7.  Studies of congenitally immunologic mutant New Zealand mice. II. Absence of T cell progenitor populations and B cell defects of congenitally athymic (nude) New Zealand Black (NZB) mice.

Authors:  M E Gershwin; J J Castles; K Erickson; A Ahmed
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

8.  Induction of autoimmune phenomena in normal mice treated with natural thymocytotoxic autoantibody.

Authors:  A Nakanishi; Y Imai; T Nakano; T Osawa
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

9.  Natural thymocytotoxic autoantibody and reactive antigen in New Zealand black and other mice.

Authors:  T Shirai; R C Mellors
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

10.  Characterization of self-reactive B cells by polyclonal B-cell activators.

Authors:  D Primi; L Hammarström; C I Smith; G Möller
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.